MPI in the study "Enhancing Measurement and Characterization of Roles and Experiences of Sexual and Gender Minority Caregivers of Persons living with Alzheimer's Disease and Related Dementias" that aims to identify domains and develop new measures of ADRD caregiving, test and validate these measures, and ensure measures are inclusive and accurately capture caregiving constructs and experiences of diverse SGM ADRD caregivers.Co-Investigator in the study "Building Community and Research Engagement among Sexual and Gender Minority Older Adults at Risk for Alzheimer’s Disease and Related Dementias" with the goal of engaging, motivating, and recruiting 1,000+ sexual and gender minority (SGM) people living with Alzheimer’s disease and related dementias (ADRD) and SGM caregivers of people living with ADRD to participate in a research registry.Co-Investigator in the study "Understanding Lactate Catabolic Pathway by BACH1 in Breast Cancer; a study that seeks to define lactate oxidation by BACH1 using flux analysis and metabolomics profiling and delineate molecular mechanisms by which BACH1 regulates transcription of lactate catabolic genes.

Co-Investigator in the Prevention of Alzheimer's disease in Women: Risks and Benefits of Hormone Therapy, a study to assess the long-term risks and benefits of mHT on AD pathophysiology, cognitive, and mood health in women who were treated with transdermal 17β-estradiol (tE2) and oCEE compared to placebo during early postmenopause, which is considered to be the “critical window” for mHT.